Gene therapy by transforming growth factor-β receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis
- 1 February 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (2) , 465-475
- https://doi.org/10.1046/j.1523-1755.1999.00275.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Glomerular up-regulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritisKidney International, 1996
- TGFβ Signaling: Receptors, Transducers, and Mad ProteinsCell, 1996
- Mechanism of activation of the TGF-β receptorNature, 1994
- Sustained expression of TGF-β1 underlies development of progressive kidney fibrosisKidney International, 1994
- Characterization of a Fusion Protein Composed of the Extracellular Domain of c-kit and the Fc Region of Human IgG Expressed in a Baculovirus SystemBiochemical and Biophysical Research Communications, 1993
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney diseaseNature, 1992
- Transforming growth factor-beta in disease: the dark side of tissue repair.Journal of Clinical Investigation, 1992
- Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 1992
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat.The Journal of cell biology, 1991